Coupling HDAC4 with transcriptional factor MEF2D abrogates SPRY4-mediated suppression of ERK activation and elicits hepatocellular carcinoma drug resistance
Author:
Funder
National Natural Science Foundation of China
Taishan Scholar Foundation of Shandong Province
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference39 articles.
1. Hepatocellular carcinoma;Llovet;Nat. Rev. Dis. Primers,2021
2. Effect of fucoidan on ethanol-induced liver injury and steatosis in mice and the underlying mechanism;Xue;Food Nutr. Res.,2021
3. An update on clinical trials in the treatment of advanced hepatocellular carcinoma;Lee;J. Clin. Gastroenterol.,2013
4. Recent advances in systemic therapy for hepatocellular carcinoma in an aging society: 2020 update;Kudo;Liver Canc.,2020
5. An ectopic network of transcription factors regulated by hippo signaling drives growth and invasion of a malignant tumor model;Atkins;Curr. Biol. : CB,2016
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Advances in hepatocellular carcinoma drug resistance models;Frontiers in Medicine;2024-07-31
2. Discovery of a novel hybrid coumarin-hydroxamate conjugate targeting the HDAC1-Sp1-FOSL2 signaling axis for breast cancer therapy;Cell Communication and Signaling;2024-07-15
3. Role of SPRY4 in health and disease;Frontiers in Oncology;2024-04-15
4. Antiphotoaging and Skin-Protective Activities of Ardisia silvestris Ethanol Extract in Human Keratinocytes;Plants;2023-03-03
5. Antioxidant, Anti-Inflammatory, Anti-Menopausal, and Anti-Cancer Effects of Lignans and Their Metabolites;International Journal of Molecular Sciences;2022-12-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3